Regional Meetings, February – April 2012

Survey Says: An Interactive Grand Rounds Series Focused on Real Cases of Patients with Colorectal Cancer

Research To Practice (RTP) is pleased to offer practicing oncologists and other allied healthcare professionals throughout the United States the opportunity to attend a live pilot educational activity focused on the management of colorectal cancer (CRC). The activity will include a blend of didactic minipresentations (using real cases as an educational framework), interactive polling of the audience utilizing personal mobile phones and follow-up discussion/audience Q&A.

Dates and Times

Faculty and Locations

 

Friday, February 17, 2012
12:00 PM – 1:00 PM EST

(Lunch will be provided)Registration is open only to oncology
professionals from this institution
Email Us for More Information »

Faculty: Howard S Hochster, MD

Location: Norwalk Hospital
Whittingham Cancer Center
24 Stevens Street
Norwalk, CT 06856

Wilcox Library, 5th Floor
 


Wednesday, March 7, 2012
8:00 AM – 9:00 AM EST

(Breakfast will be provided)Registration is also open to medical
oncologists outside of this institution
Register Here »


Faculty: Howard S Hochster, MD

Location: Aultman Cancer Center
2600 Sixth Street SW
Canton, OH 44710
Education Amphitheatre
 

Monday, March 12, 2012
12:30 PM – 1:30 PM CT

(Lunch will be provided) Registration is also open to medical
oncologists outside of this institution
Register Here »

Faculty: Cathy Eng, MD

Location: Texas Oncology-Austin Midtown
901 W 38th Street
Austin, TX 78705

Board Room, 3rd Floor
 


Wednesday, March 21, 2012
8:00 AM – 9:00 AM EST

(Breakfast will be provided)Registration is also open to medical
oncologists outside of this institution
Register Here »


Faculty: Axel Grothey, MD

Location: Aultman Cancer Center
2600 Sixth Street SW
Canton, OH 44710

Education Amphitheatre
 


Wednesday, March 21, 2012
12:30 PM – 1:30 PM EST

(Lunch will be provided) Registration is also open to medical
oncologists outside of this institution
Email Us for More Information »


Faculty: John L Marshall, MD

Location: Inova Fairfax Hospital
3300 Gallows Road
Falls Church, VA 22042

Conference Room DEF
 


Thursday, April 5, 2012
5:30 PM – 8:00 PM PT

(Dinner will be provided) Registration is open only to oncology
professionals from this institution
Email Us for More Information »


Faculty: Alan P Venook, MD

Location: City of Hope
1500 East Duarte Road
Duarte, CA 91010

Visitor Center
 


Monday, April 23, 2012
6:00 PM – 8:00 PM CT

(Dinner will be provided) Registration is open only to oncology
professionals from this institution
Email Us for More Information »


Faculty: Howard S Hochster, MD

Location for Tennessee Oncology clinicians:
Nashville, Tennessee

Venue TBC
 


Wednesday, April 25, 2012
8:00 AM – 9:00 AM EST

(Breakfast will be provided)Registration is also open to medical
oncologists outside of this institution
Register Here »


Faculty: John L Marshall, MD

Location: John Theurer Cancer Center at
Hackensack University Medical Center
92 Second Street
Hackensack, New Jersey 07601

George and June Croonquist
Conference Center, 1st Floor

 

There is no registration fee for these events. However, preregistration is advised, as seating is limited.

Each of the one-hour sessions will include 5 topic modules focused on a number of important issues in the management of CRC. Each module will employ an identical format and include:

  • Related Faculty Case Presentation
  • Audience Polling Using Text Messaging
  • Display of Steering Committee Members' Treatment Recommendations
  • Faculty Review of Select Data Sets
Module 1: Selection of treatment for metastatic CRC Module 2: Current approaches to liver-only metastases Module 3: Management of synchronous primary and metastatic disease Module 4: Biomarker assessment and adjuvant systemic treatment of colon cancer Module 5: Neoadjuvant treatment of rectal cancer Each session will conclude with a 10-minute Q&A segment

STEERING COMMITTEE MEMBERS AND PARTICIPATING FACULTY

Cathy Eng, MD
Associate Professor
Associate Medical Director
Colorectal Center
Department of Gastrointestinal
Medical Oncology
The University of Texas
MD Anderson Cancer Center
Houston, Texas

Axel Grothey, MD
Professor of Oncology
Department of Medical Oncology
Mayo Clinic
Rochester, Minnesota

Howard S Hochster, MD
Associate Director (Clinical Research)
Yale Cancer Center
Professor of Medicine
Yale School of Medicine
New Haven, Connecticut
John L Marshall, MD
Chief, Hematology and Oncology
Director, Ruesch Center for
the Cure of GI Cancers
Lombardi Comprehensive Cancer Center
Georgetown University
Washington, DC

Alan P Venook, MD
Professor of Clinical Medicine
University of California, San Francisco
San Francisco, California

PROJECT CHAIR
Neil Love, MD
Research To Practice
Miami, Florida

 

Target Audience:
This activity is intended for medical oncologists, radiation oncologists, GI surgeons and other allied professionals involved in the treatment of colorectal cancer (CRC).

Learning Objectives and Goals:
  • Employ case-based interactive learning to effectively adopt evidence-based diagnostic and therapeutic approaches for patients with CRC.
  • Appropriately integrate biomarkers and multigene assays when communicating prognosis and treatment options to patients with early-stage colon cancer.
  • Incorporate the most recent evidence regarding molecular markers in optimizing therapeutic decisions for patients with advanced CRC.
  • Apply clinical research data to optimize the use of anti-VEGF- and anti-EGFR-based therapy in the treatment of advanced CRC.
  • Compare and contrast the efficacy and safety of perioperative and postoperative systemic therapy for patients presenting with resectable or borderline resectable CRC hepatic metastases.
  • Develop an evidence-based approach regarding the use of neoadjuvant chemoradiation therapy for patients with locally advanced rectal cancer.
  • Counsel appropriately selected patients with CRC about participation in ongoing clinical trials investigating novel therapeutic agents and strategies.
CME Credit Form:
A CME credit form will be given to each participant at the conclusion of the activity.

Accreditation Statement:
Research To Practice is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation Statements:
Research To Practice designates each live activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Disclosure Policy:
As a provider accredited by the Accreditation Council for Continuing Medical Education, it is the policy of Research To Practice to require the disclosure of any significant financial interest or any other relationship the sponsor or faculty members have with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. Financial disclosures and disclosures of discussions of unlabeled/unapproved uses of drugs or devices will be provided in meeting course materials.

Supporters:
These events are supported by an educational grant from Genentech BioOncology.